top left cornertop right corner
Blackburn with Darwen Primary Care Trust - About Us

Grey Drugs Under Assessment

New drugs are constantly launched across all therapeutic areas, which makes it impossible to make timely and accurate decisions on each.  The Medicines Management Board has taken a view that once a new drug has been launched, it is automatically given a GREY traffic light;


GREY UNDER REVIEW - This is a holding position as these drugs are currently under review  by the East Lancashire Medicines Management Board pending a traffic light designation. It is recommended that GREY UNDER REVIEW medicines, are not prescribed.


As there is no need to assess all new drugs that are launched, the MMB prioritises reviews for medicines based on a variety of factors.  The lists on the pages below hope to give some information on recently launched medicines, and where they are in this process.  These decisons from the New Medicines Group (a sub-group of the Medicines Management Board) are in date order and are ratified by the Medicines Management Board.  These extracts from the minutes state whether each medicine is being proactively reviewed, has a fast tracked decision on it, or whether it hasn't been prioritised for review, but will be reviewed on request from a local health care professional.  


Grey Under Review Drugs  


Eltrompobag Revolade®   thrombocytopenia in adults with Hepatitis C
Fluarix Tetra    Influenza Vaccine








All material in this section is aimed at health professionals, but is information currently held within the public domain.   Members of the public seeking advice on medicine-related matters are encouraged to speak with their GP, pharmacist or nurse, or contact NHS Direct on 0845 46 47.  

Richard Lee, East Lancashire Health Economy New Drugs Pharmacist.


Powered by EasySite™ Content Management System